BRCA2 and ovarian carcinoma: Our results show that Wnt3A upregulates canonical β-catenin targets in ovarian cancer cells with functional BRCA1 and BRCA2, particularly the full-length WT Tcf1/7, c-Myc, and cyclin D1.